Cover Image

Evaluation of knowledge, attitude and practices towards the use of fixed dose combination of drugs among practicing doctors in a tertiary care hospital

BIACIN BABU BABUSAKKARIAS

Abstract


Fixed Dose Combinations (FDCs) improve patient compliance, decrease the chances of drug resistance and decrease pill burden. However, a major health concern is  irrational prescribing of FDCs. As practicing doctors are primarily involved in patient management at tertiary care  hospitals, knowledge about prescribing FDCs is of paramount importance. This study was aimed to evaluate knowledge,  attitude and practices towards the use of FDCs among  practicing doctors in a tertiary care hospital. The study was  carried out among the faculty and practicing doctors working at SMIMS, Kulasekharam in a tertiary care hospital. Out of fifty, thirty six practicing doctors gave their informed consent and were enrolled in the study. These practicing doctors belonged to the departments of  medicine, obstetrics and gynaecology,  surgery, orthopedics, pediatrics, dermatology, cardiology and psychiatry. A prevalidated questionnaire regarding knowledge, attitude and prescribing practice of fixed dose combinations was filled up and data was analyzed. Though the lecturers were aware about the FDCs, they did not know those that were listed by the WHO (9). The physicians were aware of all of the   advantages and disadvantages of FDCs. On an average, only 9 of the lecturers had knowledge about the Essential Medicine List (EML). Common sources of information about FDCs used by the practicing doctors were medical representatives,  colleaguespeers and medical education programmes. The most commonly prescribed FDCs by practicing doctors were of  antimicrobial drugs, amongst which amoxicillin clavulanic acid was the most frequent. This study concluded that there is need to improve knowledge about rationality of FDCs, Essential  Medical List and banned FDCs among the practicing doctors to promote the rational use of drugs.

 


Full Text:

PDF

References


Office of Combination Products. Food and Drug Administration, USA. [Accessed on 2014 March 03]. Available from-- http::/www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm109108.htm.

Kastury N, Singh S, Ansari KU. An audit of prescription for rational use of fixed dose drug combinations. Indian J Pharmacol 1999;31:367-9.

Srivastava SK. A complete textbook of Medical Pharmacology vol. 1. 1st ed. India: Avichal Publishing Company; 2012. p. 194-218.

Tripathi KD. Essentials of medical pharmacology. 7th ed. New Delhi: Jaypee brothers medical publishers; 2013. p. 512-38

Sharma HL, Sharma KK. Principles of Pharmacology. 2nd ed. Hyderabad: Paras; 2011. p. 155- 90.

World Health Organization. Essential drugs: 18th updated WHO Model List 2013. [Accessed on 2013 March 9]. Available from http://www.who.int/medicines/publications/essentialmedicines/en/

Panda J, Tiwari P, Uppal R. Evaluation of rationality of some FDC: Focus on antihypertensive drugs. Indian J Pharm Sci 2006;68:649-52.

Central drugs standard control organization. Drugs banned in India. 2013. [Accessed on 2013 March 11]. Available from: http://cdsco.nic.in/html/drugsbanned.html

Gautam CS, Aditya S. Irrational drug combinations: Need to sensitize undergraduates. Indian J Pharmacol 2006;38:169-70.

Bapna JS, Shewade DG, Pradhan SC. Training medical professionals on the concepts of essential drugs and rational drug use. Br J Clin Pharmacol 1994;37:399-400.

Goswami N, Gandhi A, Patel P, Dikshit R. An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors. Perspect Clin Res 2013;4:130-5.

Greenhalgh T. Drug prescription and self-medication in India: An exploratory survey. Soc Sci Med 1987;25:307-18.

Patel V, Vaidya R, Nalik D, Borker P. Irrational drug use in India: A prescription survey from Goa. J Postgrad Med 2005;51:9-12.

Ratnakar UP, Shenoy A, Ullal SD, Sheetal D, Shivaprakash, Pemminati S, et al. Prescribing patterns of fixed dose combinations in hypertension, diabetes mellitus and dyslipidemia among patients attending a cardiology clinic in a tertiary care teaching hospital in India. Int J Compr Pharm 2011;6:1-3.

Hogerzeil HV. Promoting rational prescribing: An international prospective. Br J Clin Pharmacol 1995;39:1-6.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University